About
L?Aptamers
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
206
By Phase
PHASE2: 1PHASE1: 2
By Status
COMPLETED: 2RECRUITING: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05962606Lead Sponsor
Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia.
PHASE2Recruiting
150 participants
Started: Feb 2, 2024 · Completed: Jun 30, 2026
NCT05343819Lead Sponsor
Ascending Multiple Intravenous Doses of AON-D21 in Healthy Male Subjects.
PHASE1Completed
16 participants
Started: Apr 12, 2022 · Completed: Nov 29, 2022
NCT05018403Lead Sponsor
First-in-human Trial With Single-dose C5a-neutralizing AON-D21 in Healthy Male Subjects
PHASE1Completed
40 participants
Started: Aug 3, 2021 · Completed: Jan 5, 2022
Locations (1)
Headquarters
Berlin, Germany
Map
Loading map...